US Stock MarketDetailed Quotes

SNSE Sensei Biotherapeutics

Watchlist
  • 0.519
  • +0.029+5.90%
Close Nov 4 16:00 ET
  • 0.510
  • -0.010-1.83%
Post 20:02 ET
13.05MMarket Cap-439P/E (TTM)

Sensei Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-23.48%7.79M
-20.69%8.73M
-26.15%37.06M
-37.60%8.14M
-44.50%7.74M
-4.99%10.18M
-11.84%11.01M
33.90%50.19M
38.62%13.05M
35.14%13.94M
Selling and administrative expenses
-40.61%3.2M
-34.30%3.81M
-5.25%18.77M
-36.02%3.65M
-17.51%3.92M
24.87%5.39M
15.34%5.8M
25.19%19.81M
64.97%5.7M
22.67%4.75M
-General and administrative expense
-40.61%3.2M
-34.30%3.81M
-5.25%18.77M
-36.02%3.65M
-17.51%3.92M
24.87%5.39M
15.34%5.8M
25.19%19.81M
64.97%5.7M
22.67%4.75M
Research and development costs
-4.18%4.58M
-5.51%4.92M
-39.77%18.3M
-38.83%4.49M
-58.45%3.82M
-25.17%4.78M
-30.19%5.2M
40.26%30.38M
23.32%7.35M
42.64%9.19M
Operating profit
23.48%-7.79M
20.69%-8.73M
26.15%-37.06M
37.60%-8.14M
44.50%-7.74M
4.99%-10.18M
11.84%-11.01M
-33.90%-50.19M
-38.62%-13.05M
-35.14%-13.94M
Net non-operating interest income expense
-29.43%645K
-20.17%740K
122.51%3.48M
-2.45%795K
67.13%844K
416.38%914K
1,283.58%927K
1,103.08%1.56M
2,810.71%815K
689.06%505K
Non-operating interest income
-29.73%669K
-20.74%768K
103.25%3.62M
35.63%826K
70.29%877K
172.78%952K
212.58%969K
122.88%1.78M
82.34%609K
85.25%515K
Non-operating interest expense
-36.84%24K
-33.33%28K
-34.25%144K
115.05%31K
230.00%33K
-77.91%38K
-82.72%42K
-67.31%219K
-167.32%-206K
-95.33%10K
Other net income (expense)
97.92%-2K
-1,536.11%-517K
-6,800.00%-67K
-1,255.00%-231K
-123K
-740.00%-96K
-93.55%36K
-94.74%1K
-96.47%20K
Special income (charges)
--0
--0
---302K
--0
---6K
---191K
---105K
--0
--0
--0
-Gain on sale of property,plant,equipment
--0
--0
---302K
--0
---6K
---191K
---105K
--0
--0
--0
Other non- operating income (expenses)
----
-122.22%-2K
-697.22%-215K
-6,800.00%-67K
-1,225.00%-225K
--68K
-40.00%9K
500.00%36K
-94.74%1K
--20K
Income before tax
23.91%-7.14M
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
Income tax
Net income
23.91%-7.14M
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
Net income continuous Operations
23.91%-7.14M
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
Minority interest income
Net income attributable to the parent company
23.91%-7.14M
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.91%-7.14M
21.47%-7.99M
29.82%-34.1M
39.39%-7.41M
46.90%-7.12M
10.91%-9.39M
17.96%-10.18M
-32.05%-48.59M
-30.60%-12.23M
-38.52%-13.42M
Basic earnings per share
9.68%-0.28
3.03%-0.32
22.78%-1.22
25.00%-0.3
36.36%-0.28
8.82%-0.31
17.50%-0.33
-18.80%-1.58
-33.33%-0.4
-37.50%-0.44
Diluted earnings per share
9.68%-0.28
3.03%-0.32
22.78%-1.22
25.00%-0.3
36.36%-0.28
8.82%-0.31
17.50%-0.33
-18.80%-1.58
-33.33%-0.4
-37.50%-0.44
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -23.48%7.79M-20.69%8.73M-26.15%37.06M-37.60%8.14M-44.50%7.74M-4.99%10.18M-11.84%11.01M33.90%50.19M38.62%13.05M35.14%13.94M
Selling and administrative expenses -40.61%3.2M-34.30%3.81M-5.25%18.77M-36.02%3.65M-17.51%3.92M24.87%5.39M15.34%5.8M25.19%19.81M64.97%5.7M22.67%4.75M
-General and administrative expense -40.61%3.2M-34.30%3.81M-5.25%18.77M-36.02%3.65M-17.51%3.92M24.87%5.39M15.34%5.8M25.19%19.81M64.97%5.7M22.67%4.75M
Research and development costs -4.18%4.58M-5.51%4.92M-39.77%18.3M-38.83%4.49M-58.45%3.82M-25.17%4.78M-30.19%5.2M40.26%30.38M23.32%7.35M42.64%9.19M
Operating profit 23.48%-7.79M20.69%-8.73M26.15%-37.06M37.60%-8.14M44.50%-7.74M4.99%-10.18M11.84%-11.01M-33.90%-50.19M-38.62%-13.05M-35.14%-13.94M
Net non-operating interest income expense -29.43%645K-20.17%740K122.51%3.48M-2.45%795K67.13%844K416.38%914K1,283.58%927K1,103.08%1.56M2,810.71%815K689.06%505K
Non-operating interest income -29.73%669K-20.74%768K103.25%3.62M35.63%826K70.29%877K172.78%952K212.58%969K122.88%1.78M82.34%609K85.25%515K
Non-operating interest expense -36.84%24K-33.33%28K-34.25%144K115.05%31K230.00%33K-77.91%38K-82.72%42K-67.31%219K-167.32%-206K-95.33%10K
Other net income (expense) 97.92%-2K-1,536.11%-517K-6,800.00%-67K-1,255.00%-231K-123K-740.00%-96K-93.55%36K-94.74%1K-96.47%20K
Special income (charges) --0--0---302K--0---6K---191K---105K--0--0--0
-Gain on sale of property,plant,equipment --0--0---302K--0---6K---191K---105K--0--0--0
Other non- operating income (expenses) -----122.22%-2K-697.22%-215K-6,800.00%-67K-1,225.00%-225K--68K-40.00%9K500.00%36K-94.74%1K--20K
Income before tax 23.91%-7.14M21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M
Income tax
Net income 23.91%-7.14M21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M
Net income continuous Operations 23.91%-7.14M21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M
Minority interest income
Net income attributable to the parent company 23.91%-7.14M21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.91%-7.14M21.47%-7.99M29.82%-34.1M39.39%-7.41M46.90%-7.12M10.91%-9.39M17.96%-10.18M-32.05%-48.59M-30.60%-12.23M-38.52%-13.42M
Basic earnings per share 9.68%-0.283.03%-0.3222.78%-1.2225.00%-0.336.36%-0.288.82%-0.3117.50%-0.33-18.80%-1.58-33.33%-0.4-37.50%-0.44
Diluted earnings per share 9.68%-0.283.03%-0.3222.78%-1.2225.00%-0.336.36%-0.288.82%-0.3117.50%-0.33-18.80%-1.58-33.33%-0.4-37.50%-0.44
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data